デフォルト表紙
市場調査レポート
商品コード
1422011

豚の病気治療薬の世界市場に関する洞察、2030年までの予測

Global Pig Disease Medication Market Insights, Forecast to 2030

出版日: | 発行: QYResearch | ページ情報: 英文 119 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
豚の病気治療薬の世界市場に関する洞察、2030年までの予測
出版日: 2024年02月08日
発行: QYResearch
ページ情報: 英文 119 Pages
納期: 2~3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、豚の病気治療薬 (Pig Disease Medication) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査対象

  • 豚の病気治療薬の製品概要
  • 市場:タイプ別
    • 世界の豚の病気治療薬 市場規模:タイプ別, 2019 VS 2023 VS 2030
    • Diarrhea
    • Virus
    • Others
  • 市場:用途別
    • 世界の豚の病気治療薬 市場規模:用途別, 2019 VS 2023 VS 2030
    • Farm
    • Household
  • 前提条件と制限
  • 調査目的
  • 対象期間

第2章 世界の豚の病気治療薬の生産

  • 世界の豚の病気治療薬の生産能力 (2019-2030)
  • 世界の豚の病気治療薬の生産 地域別: 2019 VS 2023 VS 2030
  • 世界の豚の病気治療薬の生産 地域別
    • 世界の豚の病気治療薬の生産実績:地域別 (2019-2024)
    • 世界の豚の病気治療薬の生産予測:地域別 (2025-2030)
    • 世界の豚の病気治療薬の生産 市場 シェア 地域別 (2019-2030)
  • 北米
  • 欧州
  • 中国
  • 日本

第3章 レポート概要

  • 世界の豚の病気治療薬の収益 推定および予測 2019-2030
  • 世界の豚の病気治療薬の収益:地域別
    • 世界の豚の病気治療薬の収益:地域別: 2019 VS 2023 VS 2030
    • 世界の豚の病気治療薬の収益:地域別 (2019-2024)
    • 世界の豚の病気治療薬の収益:地域別 (2025-2030)
    • 世界の豚の病気治療薬の収益市場シェア 地域別 (2019-2030)
  • 世界の豚の病気治療薬 売上予測・予想 2019-2030
  • 世界の豚の病気治療薬の販売:地域別
    • 世界の豚の病気治療薬の販売:地域別: 2019 VS 2023 VS 2030
    • 世界の豚の病気治療薬の販売:地域別 (2019-2024)
    • 世界の豚の病気治療薬の販売:地域別 (2025-2030)
    • 世界の豚の病気治療薬の販売市場シェア 地域別 (2019-2030)
  • 米国・カナダ
  • 欧州
  • 中国
  • アジア(中国を除く)
  • 中東, アフリカ ・ラテンアメリカ

第4章 競合:企業別

  • 世界の豚の病気治療薬の販売:企業別
    • 世界の豚の病気治療薬の販売:企業別 (2019-2024)
    • 世界の豚の病気治療薬の販売市場シェア:企業別 (2019-2024)
    • 世界の上位10・上位5企業: 豚の病気治療薬 in 2023
  • 世界の豚の病気治療薬の収益:企業別
    • 世界の豚の病気治療薬の収益:企業別 (2019-2024)
    • 世界の豚の病気治療薬の収益市場シェア:企業別 (2019-2024)
    • 世界の上位10・上位5企業: 豚の病気治療薬の収益 2023
  • 世界の豚の病気治療薬の販売価格:企業別
  • 世界の主要企業 豚の病気治療薬, 業界ランキング, 2022 VS 2023 VS 2024
  • 競合情勢の分析
    • 企業の市場集中度 (CR5 and HHI)
    • 世界の豚の病気治療薬の市場シェア:企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 世界の主要メーカー 豚の病気治療薬, 製造拠点分布と本社
  • 世界の主要メーカー 豚の病気治療薬, 提供製品と用途
  • 世界の主要メーカー 豚の病気治療薬, 業界参入時期
  • M&A, 拡張計画

第5章 市場規模:タイプ別

  • 世界の豚の病気治療薬の販売:タイプ別
    • 世界の豚の病気治療薬の販売実績:タイプ別 (2019-2024)
    • 世界の豚の病気治療薬の販売予測:タイプ別 (2025-2030)
    • 世界の豚の病気治療薬の販売市場シェア:タイプ別 (2019-2030)
  • 世界の豚の病気治療薬 収益:タイプ別
    • 世界の豚の病気治療薬の収益実績:タイプ別 (2019-2024)
    • 世界の豚の病気治療薬の収益予測:タイプ別 (2025-2030)
    • 世界の豚の病気治療薬の収益市場シェア:タイプ別 (2019-2030)
  • 世界の豚の病気治療薬の価格:タイプ別
    • 世界の豚の病気治療薬の価格:タイプ別 (2019-2024)
    • 世界の豚の病気治療薬の価格予測:タイプ別 (2025-2030)

第6章 市場規模:用途別

  • 世界の豚の病気治療薬の販売:用途別
    • 世界の豚の病気治療薬の販売実績:用途別 (2019-2024)
    • 世界の豚の病気治療薬の販売予測:用途別 (2025-2030)
    • 世界の豚の病気治療薬の販売市場シェア:用途別 (2019-2030)
  • 世界の豚の病気治療薬の収益:用途別
    • 世界の豚の病気治療薬の収益実績:用途別 (2019-2024)
    • 世界の豚の病気治療薬の収益予測:用途別 (2025-2030)
    • 世界の豚の病気治療薬の収益市場シェア:用途別 (2019-2030)
  • 世界の豚の病気治療薬の価格:用途別
    • 世界の豚の病気治療薬の価格:用途別 (2019-2024)
    • 世界の豚の病気治療薬の価格予測:用途別 (2025-2030)

第7章 米国・カナダ

  • 米国・カナダ 豚の病気治療薬 市場規模:タイプ別
    • 米国・カナダ 豚の病気治療薬の販売:タイプ別 (2019-2030)
    • 米国・カナダ 豚の病気治療薬 収益:タイプ別 (2019-2030)
  • 米国・カナダ 豚の病気治療薬 市場規模:用途別
    • 米国・カナダ 豚の病気治療薬の販売:用途別 (2019-2030)
    • 米国・カナダ 豚の病気治療薬の収益:用途別 (2019-2030)
  • 米国・カナダ 豚の病気治療薬の販売:国別
    • 米国・カナダ 豚の病気治療薬の収益:国別: 2019 VS 2023 VS 2030
    • 米国・カナダ 豚の病気治療薬の販売:国別 (2019-2030)
    • 米国・カナダ 豚の病気治療薬の収益:国別 (2019-2030)
    • 米国
    • カナダ

第8章 欧州

  • 欧州の豚の病気治療薬 市場規模:タイプ別
    • 欧州の豚の病気治療薬の販売:タイプ別 (2019-2030)
    • 欧州の豚の病気治療薬 収益:タイプ別 (2019-2030)
  • 欧州の豚の病気治療薬 市場規模:用途別
    • 欧州の豚の病気治療薬の販売:用途別 (2019-2030)
    • 欧州の豚の病気治療薬の収益:用途別 (2019-2030)
  • 欧州の豚の病気治療薬の販売:国別
    • 欧州の豚の病気治療薬の収益:国別: 2019 VS 2023 VS 2030
    • 欧州の豚の病気治療薬の販売:国別 (2019-2030)
    • 欧州の豚の病気治療薬の収益:国別 (2019-2030)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • オランダ

第9章 中国

  • 中国の豚の病気治療薬 市場規模:タイプ別
    • 中国の豚の病気治療薬の販売:タイプ別 (2019-2030)
    • 中国の豚の病気治療薬 収益:タイプ別 (2019-2030)
  • 中国の豚の病気治療薬 市場規模:用途別
    • 中国の豚の病気治療薬の販売:用途別 (2019-2030)
    • 中国の豚の病気治療薬の収益:用途別 (2019-2030)

第10章 アジア(中国を除く)

  • アジア地域 豚の病気治療薬 市場規模:タイプ別
    • アジア地域 豚の病気治療薬の販売:タイプ別 (2019-2030)
    • アジア地域 豚の病気治療薬 収益:タイプ別 (2019-2030)
  • アジア地域 豚の病気治療薬 市場規模:用途別
    • アジア地域 豚の病気治療薬の販売:用途別 (2019-2030)
    • アジア地域 豚の病気治療薬の収益:用途別 (2019-2030)
  • アジア地域 豚の病気治療薬の販売:地域別
    • アジア地域 豚の病気治療薬の収益:地域別: 2019 VS 2023 VS 2030
    • アジア地域 豚の病気治療薬の収益:地域別 (2019-2030)
    • アジア地域 豚の病気治療薬の販売:地域別 (2019-2030)
    • 日本
    • 韓国
    • 台湾
    • 東南アジア
    • インド

第11章 中東, アフリカ ・ラテンアメリカ

  • 中東, アフリカ ・ラテンアメリカの豚の病気治療薬 市場規模:タイプ別
    • 中東, アフリカ ・ラテンアメリカの豚の病気治療薬の販売:タイプ別 (2019-2030)
    • 中東, アフリカ ・ラテンアメリカの豚の病気治療薬 収益:タイプ別 (2019-2030)
  • 中東, アフリカ ・ラテンアメリカの豚の病気治療薬 市場規模:用途別
    • 中東, アフリカ ・ラテンアメリカの豚の病気治療薬の販売:用途別 (2019-2030)
    • 中東, アフリカ ・ラテンアメリカの豚の病気治療薬の収益:用途別 (2019-2030)
  • 中東, アフリカ ・ラテンアメリカの豚の病気治療薬の販売:国別
    • 中東, アフリカ ・ラテンアメリカの豚の病気治療薬の収益:国別: 2019 VS 2023 VS 2030
    • 中東, アフリカ ・ラテンアメリカの豚の病気治療薬の収益:国別 (2019-2030)
    • 中東, アフリカ ・ラテンアメリカの豚の病気治療薬の販売:国別 (2019-2030)
    • ブラジル
    • メキシコ
    • トルコ
    • イスラエル
    • 湾岸協力理事会諸国

第12章 企業プロファイル

  • MUGREEN
  • Tongren Pharmaceutical
  • HUADI Group
  • Kunyuan Biology
  • Hong Bao
  • Xinheng Pharmaceutical
  • Keda Animal Pharmaceutical
  • Yuan Ye Biology
  • Yi Ge Feng
  • Jiuding Animal Pharmaceutical
  • DEPOND
  • Bullvet
  • Tong Yu Group
  • Huabang Biotechnology
  • Chengkang Pharmaceutical
  • FANGTONG ANIMAL PHARMACEUTICAL
  • Jin He Biotechnology

第13章 業界チェーンと販売チャネルの分析

  • 豚の病気治療薬 業界チェーン分析
  • 豚の病気治療薬 主要原材料
    • 主要原材料
    • 原材料の主要サプライヤー
  • 豚の病気治療薬 生産形態とプロセス
  • 豚の病気治療薬 販売およびマーケティング
    • 豚の病気治療薬 販売チャネルs
    • 豚の病気治療薬 卸業者
  • 豚の病気治療薬 顧客

第14章 豚の病気治療薬 市場動向

  • 豚の病気治療薬 業界動向
  • 豚の病気治療薬 市場の促進要因
  • 豚の病気治療薬 市場の課題
  • 豚の病気治療薬 市場の抑制要因

第15章 世界の豚の病気治療薬の主な市場調査結果

第16章 付録

図表

List of Tables

  • Table 1. Global Pig Disease Medication Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
  • Table 2. Major Manufacturers of Diarrhea
  • Table 3. Major Manufacturers of Virus
  • Table 4. Major Manufacturers of Others
  • Table 5. Global Pig Disease Medication Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
  • Table 6. Global Pig Disease Medication Production by Region: 2019 VS 2023 VS 2030 (K Units)
  • Table 7. Global Pig Disease Medication Production by Region (2019-2024) & (K Units)
  • Table 8. Global Pig Disease Medication Production by Region (2025-2030) & (K Units)
  • Table 9. Global Pig Disease Medication Production Market Share by Region (2019-2024)
  • Table 10. Global Pig Disease Medication Production Market Share by Region (2025-2030)
  • Table 11. Global Pig Disease Medication Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 12. Global Pig Disease Medication Revenue by Region (2019-2024) & (US$ Million)
  • Table 13. Global Pig Disease Medication Revenue by Region (2025-2030) & (US$ Million)
  • Table 14. Global Pig Disease Medication Revenue Market Share by Region (2019-2024)
  • Table 15. Global Pig Disease Medication Revenue Market Share by Region (2025-2030)
  • Table 16. Global Pig Disease Medication Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 17. Global Pig Disease Medication Sales by Region (2019-2024) & (K Units)
  • Table 18. Global Pig Disease Medication Sales by Region (2025-2030) & (K Units)
  • Table 19. Global Pig Disease Medication Sales Market Share by Region (2019-2024)
  • Table 20. Global Pig Disease Medication Sales Market Share by Region (2025-2030)
  • Table 21. Global Pig Disease Medication Sales by Manufacturers (2019-2024) & (K Units)
  • Table 22. Global Pig Disease Medication Sales Share by Manufacturers (2019-2024)
  • Table 23. Global Pig Disease Medication Revenue by Manufacturers (2019-2024) & (US$ Million)
  • Table 24. Global Pig Disease Medication Revenue Share by Manufacturers (2019-2024)
  • Table 25. Pig Disease Medication Price by Manufacturers 2019-2024 (US$/Unit)
  • Table 26. Global Key Players of Pig Disease Medication, Industry Ranking, 2022 VS 2023 VS 2024
  • Table 27. Global Pig Disease Medication Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 28. Global Pig Disease Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pig Disease Medication as of 2023)
  • Table 29. Global Key Manufacturers of Pig Disease Medication, Manufacturing Base Distribution and Headquarters
  • Table 30. Global Key Manufacturers of Pig Disease Medication, Product Offered and Application
  • Table 31. Global Key Manufacturers of Pig Disease Medication, Date of Enter into This Industry
  • Table 32. Mergers & Acquisitions, Expansion Plans
  • Table 33. Global Pig Disease Medication Sales by Type (2019-2024) & (K Units)
  • Table 34. Global Pig Disease Medication Sales by Type (2025-2030) & (K Units)
  • Table 35. Global Pig Disease Medication Sales Share by Type (2019-2024)
  • Table 36. Global Pig Disease Medication Sales Share by Type (2025-2030)
  • Table 37. Global Pig Disease Medication Revenue by Type (2019-2024) & (US$ Million)
  • Table 38. Global Pig Disease Medication Revenue by Type (2025-2030) & (US$ Million)
  • Table 39. Global Pig Disease Medication Revenue Share by Type (2019-2024)
  • Table 40. Global Pig Disease Medication Revenue Share by Type (2025-2030)
  • Table 41. Pig Disease Medication Price by Type (2019-2024) & (US$/Unit)
  • Table 42. Global Pig Disease Medication Price Forecast by Type (2025-2030) & (US$/Unit)
  • Table 43. Global Pig Disease Medication Sales by Application (2019-2024) & (K Units)
  • Table 44. Global Pig Disease Medication Sales by Application (2025-2030) & (K Units)
  • Table 45. Global Pig Disease Medication Sales Share by Application (2019-2024)
  • Table 46. Global Pig Disease Medication Sales Share by Application (2025-2030)
  • Table 47. Global Pig Disease Medication Revenue by Application (2019-2024) & (US$ Million)
  • Table 48. Global Pig Disease Medication Revenue by Application (2025-2030) & (US$ Million)
  • Table 49. Global Pig Disease Medication Revenue Share by Application (2019-2024)
  • Table 50. Global Pig Disease Medication Revenue Share by Application (2025-2030)
  • Table 51. Pig Disease Medication Price by Application (2019-2024) & (US$/Unit)
  • Table 52. Global Pig Disease Medication Price Forecast by Application (2025-2030) & (US$/Unit)
  • Table 53. US & Canada Pig Disease Medication Sales by Type (2019-2024) & (K Units)
  • Table 54. US & Canada Pig Disease Medication Sales by Type (2025-2030) & (K Units)
  • Table 55. US & Canada Pig Disease Medication Revenue by Type (2019-2024) & (US$ Million)
  • Table 56. US & Canada Pig Disease Medication Revenue by Type (2025-2030) & (US$ Million)
  • Table 57. US & Canada Pig Disease Medication Sales by Application (2019-2024) & (K Units)
  • Table 58. US & Canada Pig Disease Medication Sales by Application (2025-2030) & (K Units)
  • Table 59. US & Canada Pig Disease Medication Revenue by Application (2019-2024) & (US$ Million)
  • Table 60. US & Canada Pig Disease Medication Revenue by Application (2025-2030) & (US$ Million)
  • Table 61. US & Canada Pig Disease Medication Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 62. US & Canada Pig Disease Medication Revenue by Country (2019-2024) & (US$ Million)
  • Table 63. US & Canada Pig Disease Medication Revenue by Country (2025-2030) & (US$ Million)
  • Table 64. US & Canada Pig Disease Medication Sales by Country (2019-2024) & (K Units)
  • Table 65. US & Canada Pig Disease Medication Sales by Country (2025-2030) & (K Units)
  • Table 66. Europe Pig Disease Medication Sales by Type (2019-2024) & (K Units)
  • Table 67. Europe Pig Disease Medication Sales by Type (2025-2030) & (K Units)
  • Table 68. Europe Pig Disease Medication Revenue by Type (2019-2024) & (US$ Million)
  • Table 69. Europe Pig Disease Medication Revenue by Type (2025-2030) & (US$ Million)
  • Table 70. Europe Pig Disease Medication Sales by Application (2019-2024) & (K Units)
  • Table 71. Europe Pig Disease Medication Sales by Application (2025-2030) & (K Units)
  • Table 72. Europe Pig Disease Medication Revenue by Application (2019-2024) & (US$ Million)
  • Table 73. Europe Pig Disease Medication Revenue by Application (2025-2030) & (US$ Million)
  • Table 74. Europe Pig Disease Medication Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 75. Europe Pig Disease Medication Revenue by Country (2019-2024) & (US$ Million)
  • Table 76. Europe Pig Disease Medication Revenue by Country (2025-2030) & (US$ Million)
  • Table 77. Europe Pig Disease Medication Sales by Country (2019-2024) & (K Units)
  • Table 78. Europe Pig Disease Medication Sales by Country (2025-2030) & (K Units)
  • Table 79. China Pig Disease Medication Sales by Type (2019-2024) & (K Units)
  • Table 80. China Pig Disease Medication Sales by Type (2025-2030) & (K Units)
  • Table 81. China Pig Disease Medication Revenue by Type (2019-2024) & (US$ Million)
  • Table 82. China Pig Disease Medication Revenue by Type (2025-2030) & (US$ Million)
  • Table 83. China Pig Disease Medication Sales by Application (2019-2024) & (K Units)
  • Table 84. China Pig Disease Medication Sales by Application (2025-2030) & (K Units)
  • Table 85. China Pig Disease Medication Revenue by Application (2019-2024) & (US$ Million)
  • Table 86. China Pig Disease Medication Revenue by Application (2025-2030) & (US$ Million)
  • Table 87. Asia Pig Disease Medication Sales by Type (2019-2024) & (K Units)
  • Table 88. Asia Pig Disease Medication Sales by Type (2025-2030) & (K Units)
  • Table 89. Asia Pig Disease Medication Revenue by Type (2019-2024) & (US$ Million)
  • Table 90. Asia Pig Disease Medication Revenue by Type (2025-2030) & (US$ Million)
  • Table 91. Asia Pig Disease Medication Sales by Application (2019-2024) & (K Units)
  • Table 92. Asia Pig Disease Medication Sales by Application (2025-2030) & (K Units)
  • Table 93. Asia Pig Disease Medication Revenue by Application (2019-2024) & (US$ Million)
  • Table 94. Asia Pig Disease Medication Revenue by Application (2025-2030) & (US$ Million)
  • Table 95. Asia Pig Disease Medication Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 96. Asia Pig Disease Medication Revenue by Region (2019-2024) & (US$ Million)
  • Table 97. Asia Pig Disease Medication Revenue by Region (2025-2030) & (US$ Million)
  • Table 98. Asia Pig Disease Medication Sales by Region (2019-2024) & (K Units)
  • Table 99. Asia Pig Disease Medication Sales by Region (2025-2030) & (K Units)
  • Table 100. Middle East, Africa and Latin America Pig Disease Medication Sales by Type (2019-2024) & (K Units)
  • Table 101. Middle East, Africa and Latin America Pig Disease Medication Sales by Type (2025-2030) & (K Units)
  • Table 102. Middle East, Africa and Latin America Pig Disease Medication Revenue by Type (2019-2024) & (US$ Million)
  • Table 103. Middle East, Africa and Latin America Pig Disease Medication Revenue by Type (2025-2030) & (US$ Million)
  • Table 104. Middle East, Africa and Latin America Pig Disease Medication Sales by Application (2019-2024) & (K Units)
  • Table 105. Middle East, Africa and Latin America Pig Disease Medication Sales by Application (2025-2030) & (K Units)
  • Table 106. Middle East, Africa and Latin America Pig Disease Medication Revenue by Application (2019-2024) & (US$ Million)
  • Table 107. Middle East, Africa and Latin America Pig Disease Medication Revenue by Application (2025-2030) & (US$ Million)
  • Table 108. Middle East, Africa and Latin America Pig Disease Medication Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 109. Middle East, Africa and Latin America Pig Disease Medication Revenue by Country (2019-2024) & (US$ Million)
  • Table 110. Middle East, Africa and Latin America Pig Disease Medication Revenue by Country (2025-2030) & (US$ Million)
  • Table 111. Middle East, Africa and Latin America Pig Disease Medication Sales by Country (2019-2024) & (K Units)
  • Table 112. Middle East, Africa and Latin America Pig Disease Medication Sales by Country (2025-2030) & (K Units)
  • Table 113. MUGREEN Company Information
  • Table 114. MUGREEN Description and Major Businesses
  • Table 115. MUGREEN Pig Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 116. MUGREEN Pig Disease Medication Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 117. MUGREEN Recent Development
  • Table 118. Tongren Pharmaceutical Company Information
  • Table 119. Tongren Pharmaceutical Description and Major Businesses
  • Table 120. Tongren Pharmaceutical Pig Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 121. Tongren Pharmaceutical Pig Disease Medication Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 122. Tongren Pharmaceutical Recent Development
  • Table 123. HUADI Group Company Information
  • Table 124. HUADI Group Description and Major Businesses
  • Table 125. HUADI Group Pig Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 126. HUADI Group Pig Disease Medication Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 127. HUADI Group Recent Development
  • Table 128. Kunyuan Biology Company Information
  • Table 129. Kunyuan Biology Description and Major Businesses
  • Table 130. Kunyuan Biology Pig Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 131. Kunyuan Biology Pig Disease Medication Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 132. Kunyuan Biology Recent Development
  • Table 133. Hong Bao Company Information
  • Table 134. Hong Bao Description and Major Businesses
  • Table 135. Hong Bao Pig Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 136. Hong Bao Pig Disease Medication Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 137. Hong Bao Recent Development
  • Table 138. Xinheng Pharmaceutical Company Information
  • Table 139. Xinheng Pharmaceutical Description and Major Businesses
  • Table 140. Xinheng Pharmaceutical Pig Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 141. Xinheng Pharmaceutical Pig Disease Medication Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 142. Xinheng Pharmaceutical Recent Development
  • Table 143. Keda Animal Pharmaceutical Company Information
  • Table 144. Keda Animal Pharmaceutical Description and Major Businesses
  • Table 145. Keda Animal Pharmaceutical Pig Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 146. Keda Animal Pharmaceutical Pig Disease Medication Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 147. Keda Animal Pharmaceutical Recent Development
  • Table 148. Yuan Ye Biology Company Information
  • Table 149. Yuan Ye Biology Description and Major Businesses
  • Table 150. Yuan Ye Biology Pig Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 151. Yuan Ye Biology Pig Disease Medication Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 152. Yuan Ye Biology Recent Development
  • Table 153. Yi Ge Feng Company Information
  • Table 154. Yi Ge Feng Description and Major Businesses
  • Table 155. Yi Ge Feng Pig Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 156. Yi Ge Feng Pig Disease Medication Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 157. Yi Ge Feng Recent Development
  • Table 158. Jiuding Animal Pharmaceutical Company Information
  • Table 159. Jiuding Animal Pharmaceutical Description and Major Businesses
  • Table 160. Jiuding Animal Pharmaceutical Pig Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 161. Jiuding Animal Pharmaceutical Pig Disease Medication Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 162. Jiuding Animal Pharmaceutical Recent Development
  • Table 163. DEPOND Company Information
  • Table 164. DEPOND Description and Major Businesses
  • Table 165. DEPOND Pig Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 166. DEPOND Pig Disease Medication Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 167. DEPOND Recent Development
  • Table 168. Bullvet Company Information
  • Table 169. Bullvet Description and Major Businesses
  • Table 170. Bullvet Pig Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 171. Bullvet Pig Disease Medication Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 172. Bullvet Recent Development
  • Table 173. Tong Yu Group Company Information
  • Table 174. Tong Yu Group Description and Major Businesses
  • Table 175. Tong Yu Group Pig Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 176. Tong Yu Group Pig Disease Medication Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 177. Tong Yu Group Recent Development
  • Table 178. Huabang Biotechnology Company Information
  • Table 179. Huabang Biotechnology Description and Major Businesses
  • Table 180. Huabang Biotechnology Pig Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 181. Huabang Biotechnology Pig Disease Medication Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 182. Huabang Biotechnology Recent Development
  • Table 183. Chengkang Pharmaceutical Company Information
  • Table 184. Chengkang Pharmaceutical Description and Major Businesses
  • Table 185. Chengkang Pharmaceutical Pig Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 186. Chengkang Pharmaceutical Pig Disease Medication Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 187. Chengkang Pharmaceutical Recent Development
  • Table 188. FANGTONG ANIMAL PHARMACEUTICAL Company Information
  • Table 189. FANGTONG ANIMAL PHARMACEUTICAL Description and Major Businesses
  • Table 190. FANGTONG ANIMAL PHARMACEUTICAL Pig Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 191. FANGTONG ANIMAL PHARMACEUTICAL Pig Disease Medication Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 192. FANGTONG ANIMAL PHARMACEUTICAL Recent Development
  • Table 193. Jin He Biotechnology Company Information
  • Table 194. Jin He Biotechnology Description and Major Businesses
  • Table 195. Jin He Biotechnology Pig Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 196. Jin He Biotechnology Pig Disease Medication Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 197. Jin He Biotechnology Recent Development
  • Table 198. Key Raw Materials Lists
  • Table 199. Raw Materials Key Suppliers Lists
  • Table 200. Pig Disease Medication Distributors List
  • Table 201. Pig Disease Medication Customers List
  • Table 202. Pig Disease Medication Market Trends
  • Table 203. Pig Disease Medication Market Drivers
  • Table 204. Pig Disease Medication Market Challenges
  • Table 205. Pig Disease Medication Market Restraints
  • Table 206. Research Programs/Design for This Report
  • Table 207. Key Data Information from Secondary Sources
  • Table 208. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Pig Disease Medication Product Picture
  • Figure 2. Global Pig Disease Medication Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
  • Figure 3. Global Pig Disease Medication Market Share by Type in 2023 & 2030
  • Figure 4. Diarrhea Product Picture
  • Figure 5. Virus Product Picture
  • Figure 6. Others Product Picture
  • Figure 7. Global Pig Disease Medication Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
  • Figure 8. Global Pig Disease Medication Market Share by Application in 2023 & 2030
  • Figure 9. Farm
  • Figure 10. Household
  • Figure 11. Pig Disease Medication Report Years Considered
  • Figure 12. Global Pig Disease Medication Capacity, Production and Utilization (2019-2030) & (K Units)
  • Figure 13. Global Pig Disease Medication Production Market Share by Region in Percentage: 2023 Versus 2030
  • Figure 14. Global Pig Disease Medication Production Market Share by Region (2019-2030)
  • Figure 15. Pig Disease Medication Production Growth Rate in North America (2019-2030) & (K Units)
  • Figure 16. Pig Disease Medication Production Growth Rate in Europe (2019-2030) & (K Units)
  • Figure 17. Pig Disease Medication Production Growth Rate in China (2019-2030) & (K Units)
  • Figure 18. Pig Disease Medication Production Growth Rate in Japan (2019-2030) & (K Units)
  • Figure 19. Global Pig Disease Medication Revenue, (US$ Million), 2019 VS 2023 VS 2030
  • Figure 20. Global Pig Disease Medication Revenue 2019-2030 (US$ Million)
  • Figure 21. Global Pig Disease Medication Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
  • Figure 22. Global Pig Disease Medication Revenue Market Share by Region in Percentage: 2023 Versus 2030
  • Figure 23. Global Pig Disease Medication Revenue Market Share by Region (2019-2030)
  • Figure 24. Global Pig Disease Medication Sales 2019-2030 ((K Units)
  • Figure 25. Global Pig Disease Medication Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)
  • Figure 26. Global Pig Disease Medication Sales Market Share by Region (2019-2030)
  • Figure 27. US & Canada Pig Disease Medication Sales YoY (2019-2030) & (K Units)
  • Figure 28. US & Canada Pig Disease Medication Revenue YoY (2019-2030) & (US$ Million)
  • Figure 29. Europe Pig Disease Medication Sales YoY (2019-2030) & (K Units)
  • Figure 30. Europe Pig Disease Medication Revenue YoY (2019-2030) & (US$ Million)
  • Figure 31. China Pig Disease Medication Sales YoY (2019-2030) & (K Units)
  • Figure 32. China Pig Disease Medication Revenue YoY (2019-2030) & (US$ Million)
  • Figure 33. Asia (excluding China) Pig Disease Medication Sales YoY (2019-2030) & (K Units)
  • Figure 34. Asia (excluding China) Pig Disease Medication Revenue YoY (2019-2030) & (US$ Million)
  • Figure 35. Middle East, Africa and Latin America Pig Disease Medication Sales YoY (2019-2030) & (K Units)
  • Figure 36. Middle East, Africa and Latin America Pig Disease Medication Revenue YoY (2019-2030) & (US$ Million)
  • Figure 37. The Pig Disease Medication Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
  • Figure 38. The Top 5 and 10 Largest Manufacturers of Pig Disease Medication in the World: Market Share by Pig Disease Medication Revenue in 2023
  • Figure 39. Global Pig Disease Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
  • Figure 40. Global Pig Disease Medication Sales Market Share by Type (2019-2030)
  • Figure 41. Global Pig Disease Medication Revenue Market Share by Type (2019-2030)
  • Figure 42. Global Pig Disease Medication Sales Market Share by Application (2019-2030)
  • Figure 43. Global Pig Disease Medication Revenue Market Share by Application (2019-2030)
  • Figure 44. US & Canada Pig Disease Medication Sales Market Share by Type (2019-2030)
  • Figure 45. US & Canada Pig Disease Medication Revenue Market Share by Type (2019-2030)
  • Figure 46. US & Canada Pig Disease Medication Sales Market Share by Application (2019-2030)
  • Figure 47. US & Canada Pig Disease Medication Revenue Market Share by Application (2019-2030)
  • Figure 48. US & Canada Pig Disease Medication Revenue Share by Country (2019-2030)
  • Figure 49. US & Canada Pig Disease Medication Sales Share by Country (2019-2030)
  • Figure 50. U.S. Pig Disease Medication Revenue (2019-2030) & (US$ Million)
  • Figure 51. Canada Pig Disease Medication Revenue (2019-2030) & (US$ Million)
  • Figure 52. Europe Pig Disease Medication Sales Market Share by Type (2019-2030)
  • Figure 53. Europe Pig Disease Medication Revenue Market Share by Type (2019-2030)
  • Figure 54. Europe Pig Disease Medication Sales Market Share by Application (2019-2030)
  • Figure 55. Europe Pig Disease Medication Revenue Market Share by Application (2019-2030)
  • Figure 56. Europe Pig Disease Medication Revenue Share by Country (2019-2030)
  • Figure 57. Europe Pig Disease Medication Sales Share by Country (2019-2030)
  • Figure 58. Germany Pig Disease Medication Revenue (2019-2030) & (US$ Million)
  • Figure 59. France Pig Disease Medication Revenue (2019-2030) & (US$ Million)
  • Figure 60. U.K. Pig Disease Medication Revenue (2019-2030) & (US$ Million)
  • Figure 61. Italy Pig Disease Medication Revenue (2019-2030) & (US$ Million)
  • Figure 62. Netherlands Pig Disease Medication Revenue (2019-2030) & (US$ Million)
  • Figure 63. China Pig Disease Medication Sales Market Share by Type (2019-2030)
  • Figure 64. China Pig Disease Medication Revenue Market Share by Type (2019-2030)
  • Figure 65. China Pig Disease Medication Sales Market Share by Application (2019-2030)
  • Figure 66. China Pig Disease Medication Revenue Market Share by Application (2019-2030)
  • Figure 67. Asia Pig Disease Medication Sales Market Share by Type (2019-2030)
  • Figure 68. Asia Pig Disease Medication Revenue Market Share by Type (2019-2030)
  • Figure 69. Asia Pig Disease Medication Sales Market Share by Application (2019-2030)
  • Figure 70. Asia Pig Disease Medication Revenue Market Share by Application (2019-2030)
  • Figure 71. Asia Pig Disease Medication Revenue Share by Region (2019-2030)
  • Figure 72. Asia Pig Disease Medication Sales Share by Region (2019-2030)
  • Figure 73. Japan Pig Disease Medication Revenue (2019-2030) & (US$ Million)
  • Figure 74. South Korea Pig Disease Medication Revenue (2019-2030) & (US$ Million)
  • Figure 75. China Taiwan Pig Disease Medication Revenue (2019-2030) & (US$ Million)
  • Figure 76. Southeast Asia Pig Disease Medication Revenue (2019-2030) & (US$ Million)
  • Figure 77. India Pig Disease Medication Revenue (2019-2030) & (US$ Million)
  • Figure 78. Middle East, Africa and Latin America Pig Disease Medication Sales Market Share by Type (2019-2030)
  • Figure 79. Middle East, Africa and Latin America Pig Disease Medication Revenue Market Share by Type (2019-2030)
  • Figure 80. Middle East, Africa and Latin America Pig Disease Medication Sales Market Share by Application (2019-2030)
  • Figure 81. Middle East, Africa and Latin America Pig Disease Medication Revenue Market Share by Application (2019-2030)
  • Figure 82. Middle East, Africa and Latin America Pig Disease Medication Revenue Share by Country (2019-2030)
  • Figure 83. Middle East, Africa and Latin America Pig Disease Medication Sales Share by Country (2019-2030)
  • Figure 84. Brazil Pig Disease Medication Revenue (2019-2030) & (US$ Million)
  • Figure 85. Mexico Pig Disease Medication Revenue (2019-2030) & (US$ Million)
  • Figure 86. Turkey Pig Disease Medication Revenue (2019-2030) & (US$ Million)
  • Figure 87. Israel Pig Disease Medication Revenue (2019-2030) & (US$ Million)
  • Figure 88. GCC Countries Pig Disease Medication Revenue (2019-2030) & (US$ Million)
  • Figure 89. Pig Disease Medication Value Chain
  • Figure 90. Pig Disease Medication Production Process
  • Figure 91. Channels of Distribution
  • Figure 92. Distributors Profiles
  • Figure 93. Bottom-up and Top-down Approaches for This Report
  • Figure 94. Data Triangulation
  • Figure 95. Key Executives Interviewed
目次

This research report focuses on the Pig Disease Medication Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 Pig Disease Medication Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Pig Disease Medication Market Size by Type, 2019 VS 2023 VS 2030
    • 1.2.2 Diarrhea
    • 1.2.3 Virus
    • 1.2.4 Others
  • 1.3 Market by Application
    • 1.3.1 Global Pig Disease Medication Market Size by Application, 2019 VS 2023 VS 2030
    • 1.3.2 Farm
    • 1.3.3 Household
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Pig Disease Medication Production

  • 2.1 Global Pig Disease Medication Production Capacity (2019-2030)
  • 2.2 Global Pig Disease Medication Production by Region: 2019 VS 2023 VS 2030
  • 2.3 Global Pig Disease Medication Production by Region
    • 2.3.1 Global Pig Disease Medication Historic Production by Region (2019-2024)
    • 2.3.2 Global Pig Disease Medication Forecasted Production by Region (2025-2030)
    • 2.3.3 Global Pig Disease Medication Production Market Share by Region (2019-2030)
  • 2.4 North America
  • 2.5 Europe
  • 2.6 China
  • 2.7 Japan

3 Executive Summary

  • 3.1 Global Pig Disease Medication Revenue Estimates and Forecasts 2019-2030
  • 3.2 Global Pig Disease Medication Revenue by Region
    • 3.2.1 Global Pig Disease Medication Revenue by Region: 2019 VS 2023 VS 2030
    • 3.2.2 Global Pig Disease Medication Revenue by Region (2019-2024)
    • 3.2.3 Global Pig Disease Medication Revenue by Region (2025-2030)
    • 3.2.4 Global Pig Disease Medication Revenue Market Share by Region (2019-2030)
  • 3.3 Global Pig Disease Medication Sales Estimates and Forecasts 2019-2030
  • 3.4 Global Pig Disease Medication Sales by Region
    • 3.4.1 Global Pig Disease Medication Sales by Region: 2019 VS 2023 VS 2030
    • 3.4.2 Global Pig Disease Medication Sales by Region (2019-2024)
    • 3.4.3 Global Pig Disease Medication Sales by Region (2025-2030)
    • 3.4.4 Global Pig Disease Medication Sales Market Share by Region (2019-2030)
  • 3.5 US & Canada
  • 3.6 Europe
  • 3.7 China
  • 3.8 Asia (excluding China)
  • 3.9 Middle East, Africa and Latin America

4 Competition by Manufactures

  • 4.1 Global Pig Disease Medication Sales by Manufacturers
    • 4.1.1 Global Pig Disease Medication Sales by Manufacturers (2019-2024)
    • 4.1.2 Global Pig Disease Medication Sales Market Share by Manufacturers (2019-2024)
    • 4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pig Disease Medication in 2023
  • 4.2 Global Pig Disease Medication Revenue by Manufacturers
    • 4.2.1 Global Pig Disease Medication Revenue by Manufacturers (2019-2024)
    • 4.2.2 Global Pig Disease Medication Revenue Market Share by Manufacturers (2019-2024)
    • 4.2.3 Global Top 10 and Top 5 Companies by Pig Disease Medication Revenue in 2023
  • 4.3 Global Pig Disease Medication Sales Price by Manufacturers
  • 4.4 Global Key Players of Pig Disease Medication, Industry Ranking, 2022 VS 2023 VS 2024
  • 4.5 Analysis of Competitive Landscape
    • 4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 4.5.2 Global Pig Disease Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 4.6 Global Key Manufacturers of Pig Disease Medication, Manufacturing Base Distribution and Headquarters
  • 4.7 Global Key Manufacturers of Pig Disease Medication, Product Offered and Application
  • 4.8 Global Key Manufacturers of Pig Disease Medication, Date of Enter into This Industry
  • 4.9 Mergers & Acquisitions, Expansion Plans

5 Market Size by Type

  • 5.1 Global Pig Disease Medication Sales by Type
    • 5.1.1 Global Pig Disease Medication Historical Sales by Type (2019-2024)
    • 5.1.2 Global Pig Disease Medication Forecasted Sales by Type (2025-2030)
    • 5.1.3 Global Pig Disease Medication Sales Market Share by Type (2019-2030)
  • 5.2 Global Pig Disease Medication Revenue by Type
    • 5.2.1 Global Pig Disease Medication Historical Revenue by Type (2019-2024)
    • 5.2.2 Global Pig Disease Medication Forecasted Revenue by Type (2025-2030)
    • 5.2.3 Global Pig Disease Medication Revenue Market Share by Type (2019-2030)
  • 5.3 Global Pig Disease Medication Price by Type
    • 5.3.1 Global Pig Disease Medication Price by Type (2019-2024)
    • 5.3.2 Global Pig Disease Medication Price Forecast by Type (2025-2030)

6 Market Size by Application

  • 6.1 Global Pig Disease Medication Sales by Application
    • 6.1.1 Global Pig Disease Medication Historical Sales by Application (2019-2024)
    • 6.1.2 Global Pig Disease Medication Forecasted Sales by Application (2025-2030)
    • 6.1.3 Global Pig Disease Medication Sales Market Share by Application (2019-2030)
  • 6.2 Global Pig Disease Medication Revenue by Application
    • 6.2.1 Global Pig Disease Medication Historical Revenue by Application (2019-2024)
    • 6.2.2 Global Pig Disease Medication Forecasted Revenue by Application (2025-2030)
    • 6.2.3 Global Pig Disease Medication Revenue Market Share by Application (2019-2030)
  • 6.3 Global Pig Disease Medication Price by Application
    • 6.3.1 Global Pig Disease Medication Price by Application (2019-2024)
    • 6.3.2 Global Pig Disease Medication Price Forecast by Application (2025-2030)

7 US & Canada

  • 7.1 US & Canada Pig Disease Medication Market Size by Type
    • 7.1.1 US & Canada Pig Disease Medication Sales by Type (2019-2030)
    • 7.1.2 US & Canada Pig Disease Medication Revenue by Type (2019-2030)
  • 7.2 US & Canada Pig Disease Medication Market Size by Application
    • 7.2.1 US & Canada Pig Disease Medication Sales by Application (2019-2030)
    • 7.2.2 US & Canada Pig Disease Medication Revenue by Application (2019-2030)
  • 7.3 US & Canada Pig Disease Medication Sales by Country
    • 7.3.1 US & Canada Pig Disease Medication Revenue by Country: 2019 VS 2023 VS 2030
    • 7.3.2 US & Canada Pig Disease Medication Sales by Country (2019-2030)
    • 7.3.3 US & Canada Pig Disease Medication Revenue by Country (2019-2030)
    • 7.3.4 United States
    • 7.3.5 Canada

8 Europe

  • 8.1 Europe Pig Disease Medication Market Size by Type
    • 8.1.1 Europe Pig Disease Medication Sales by Type (2019-2030)
    • 8.1.2 Europe Pig Disease Medication Revenue by Type (2019-2030)
  • 8.2 Europe Pig Disease Medication Market Size by Application
    • 8.2.1 Europe Pig Disease Medication Sales by Application (2019-2030)
    • 8.2.2 Europe Pig Disease Medication Revenue by Application (2019-2030)
  • 8.3 Europe Pig Disease Medication Sales by Country
    • 8.3.1 Europe Pig Disease Medication Revenue by Country: 2019 VS 2023 VS 2030
    • 8.3.2 Europe Pig Disease Medication Sales by Country (2019-2030)
    • 8.3.3 Europe Pig Disease Medication Revenue by Country (2019-2030)
    • 8.3.4 Germany
    • 8.3.5 France
    • 8.3.6 U.K.
    • 8.3.7 Italy
    • 8.3.8 Netherlands

9 China

  • 9.1 China Pig Disease Medication Market Size by Type
    • 9.1.1 China Pig Disease Medication Sales by Type (2019-2030)
    • 9.1.2 China Pig Disease Medication Revenue by Type (2019-2030)
  • 9.2 China Pig Disease Medication Market Size by Application
    • 9.2.1 China Pig Disease Medication Sales by Application (2019-2030)
    • 9.2.2 China Pig Disease Medication Revenue by Application (2019-2030)

10 Asia (excluding China)

  • 10.1 Asia Pig Disease Medication Market Size by Type
    • 10.1.1 Asia Pig Disease Medication Sales by Type (2019-2030)
    • 10.1.2 Asia Pig Disease Medication Revenue by Type (2019-2030)
  • 10.2 Asia Pig Disease Medication Market Size by Application
    • 10.2.1 Asia Pig Disease Medication Sales by Application (2019-2030)
    • 10.2.2 Asia Pig Disease Medication Revenue by Application (2019-2030)
  • 10.3 Asia Pig Disease Medication Sales by Region
    • 10.3.1 Asia Pig Disease Medication Revenue by Region: 2019 VS 2023 VS 2030
    • 10.3.2 Asia Pig Disease Medication Revenue by Region (2019-2030)
    • 10.3.3 Asia Pig Disease Medication Sales by Region (2019-2030)
    • 10.3.4 Japan
    • 10.3.5 South Korea
    • 10.3.6 China Taiwan
    • 10.3.7 Southeast Asia
    • 10.3.8 India

11 Middle East, Africa and Latin America

  • 11.1 Middle East, Africa and Latin America Pig Disease Medication Market Size by Type
    • 11.1.1 Middle East, Africa and Latin America Pig Disease Medication Sales by Type (2019-2030)
    • 11.1.2 Middle East, Africa and Latin America Pig Disease Medication Revenue by Type (2019-2030)
  • 11.2 Middle East, Africa and Latin America Pig Disease Medication Market Size by Application
    • 11.2.1 Middle East, Africa and Latin America Pig Disease Medication Sales by Application (2019-2030)
    • 11.2.2 Middle East, Africa and Latin America Pig Disease Medication Revenue by Application (2019-2030)
  • 11.3 Middle East, Africa and Latin America Pig Disease Medication Sales by Country
    • 11.3.1 Middle East, Africa and Latin America Pig Disease Medication Revenue by Country: 2019 VS 2023 VS 2030
    • 11.3.2 Middle East, Africa and Latin America Pig Disease Medication Revenue by Country (2019-2030)
    • 11.3.3 Middle East, Africa and Latin America Pig Disease Medication Sales by Country (2019-2030)
    • 11.3.4 Brazil
    • 11.3.5 Mexico
    • 11.3.6 Turkey
    • 11.3.7 Israel
    • 11.3.8 GCC Countries

12 Corporate Profiles

  • 12.1 MUGREEN
    • 12.1.1 MUGREEN Company Information
    • 12.1.2 MUGREEN Overview
    • 12.1.3 MUGREEN Pig Disease Medication Sales, Price, Revenue and Gross Margin (2019-2024)
    • 12.1.4 MUGREEN Pig Disease Medication Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.1.5 MUGREEN Recent Developments
  • 12.2 Tongren Pharmaceutical
    • 12.2.1 Tongren Pharmaceutical Company Information
    • 12.2.2 Tongren Pharmaceutical Overview
    • 12.2.3 Tongren Pharmaceutical Pig Disease Medication Sales, Price, Revenue and Gross Margin (2019-2024)
    • 12.2.4 Tongren Pharmaceutical Pig Disease Medication Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.2.5 Tongren Pharmaceutical Recent Developments
  • 12.3 HUADI Group
    • 12.3.1 HUADI Group Company Information
    • 12.3.2 HUADI Group Overview
    • 12.3.3 HUADI Group Pig Disease Medication Sales, Price, Revenue and Gross Margin (2019-2024)
    • 12.3.4 HUADI Group Pig Disease Medication Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.3.5 HUADI Group Recent Developments
  • 12.4 Kunyuan Biology
    • 12.4.1 Kunyuan Biology Company Information
    • 12.4.2 Kunyuan Biology Overview
    • 12.4.3 Kunyuan Biology Pig Disease Medication Sales, Price, Revenue and Gross Margin (2019-2024)
    • 12.4.4 Kunyuan Biology Pig Disease Medication Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.4.5 Kunyuan Biology Recent Developments
  • 12.5 Hong Bao
    • 12.5.1 Hong Bao Company Information
    • 12.5.2 Hong Bao Overview
    • 12.5.3 Hong Bao Pig Disease Medication Sales, Price, Revenue and Gross Margin (2019-2024)
    • 12.5.4 Hong Bao Pig Disease Medication Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.5.5 Hong Bao Recent Developments
  • 12.6 Xinheng Pharmaceutical
    • 12.6.1 Xinheng Pharmaceutical Company Information
    • 12.6.2 Xinheng Pharmaceutical Overview
    • 12.6.3 Xinheng Pharmaceutical Pig Disease Medication Sales, Price, Revenue and Gross Margin (2019-2024)
    • 12.6.4 Xinheng Pharmaceutical Pig Disease Medication Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.6.5 Xinheng Pharmaceutical Recent Developments
  • 12.7 Keda Animal Pharmaceutical
    • 12.7.1 Keda Animal Pharmaceutical Company Information
    • 12.7.2 Keda Animal Pharmaceutical Overview
    • 12.7.3 Keda Animal Pharmaceutical Pig Disease Medication Sales, Price, Revenue and Gross Margin (2019-2024)
    • 12.7.4 Keda Animal Pharmaceutical Pig Disease Medication Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.7.5 Keda Animal Pharmaceutical Recent Developments
  • 12.8 Yuan Ye Biology
    • 12.8.1 Yuan Ye Biology Company Information
    • 12.8.2 Yuan Ye Biology Overview
    • 12.8.3 Yuan Ye Biology Pig Disease Medication Sales, Price, Revenue and Gross Margin (2019-2024)
    • 12.8.4 Yuan Ye Biology Pig Disease Medication Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.8.5 Yuan Ye Biology Recent Developments
  • 12.9 Yi Ge Feng
    • 12.9.1 Yi Ge Feng Company Information
    • 12.9.2 Yi Ge Feng Overview
    • 12.9.3 Yi Ge Feng Pig Disease Medication Sales, Price, Revenue and Gross Margin (2019-2024)
    • 12.9.4 Yi Ge Feng Pig Disease Medication Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.9.5 Yi Ge Feng Recent Developments
  • 12.10 Jiuding Animal Pharmaceutical
    • 12.10.1 Jiuding Animal Pharmaceutical Company Information
    • 12.10.2 Jiuding Animal Pharmaceutical Overview
    • 12.10.3 Jiuding Animal Pharmaceutical Pig Disease Medication Sales, Price, Revenue and Gross Margin (2019-2024)
    • 12.10.4 Jiuding Animal Pharmaceutical Pig Disease Medication Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.10.5 Jiuding Animal Pharmaceutical Recent Developments
  • 12.11 DEPOND
    • 12.11.1 DEPOND Company Information
    • 12.11.2 DEPOND Overview
    • 12.11.3 DEPOND Pig Disease Medication Sales, Price, Revenue and Gross Margin (2019-2024)
    • 12.11.4 DEPOND Pig Disease Medication Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.11.5 DEPOND Recent Developments
  • 12.12 Bullvet
    • 12.12.1 Bullvet Company Information
    • 12.12.2 Bullvet Overview
    • 12.12.3 Bullvet Pig Disease Medication Sales, Price, Revenue and Gross Margin (2019-2024)
    • 12.12.4 Bullvet Pig Disease Medication Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.12.5 Bullvet Recent Developments
  • 12.13 Tong Yu Group
    • 12.13.1 Tong Yu Group Company Information
    • 12.13.2 Tong Yu Group Overview
    • 12.13.3 Tong Yu Group Pig Disease Medication Sales, Price, Revenue and Gross Margin (2019-2024)
    • 12.13.4 Tong Yu Group Pig Disease Medication Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.13.5 Tong Yu Group Recent Developments
  • 12.14 Huabang Biotechnology
    • 12.14.1 Huabang Biotechnology Company Information
    • 12.14.2 Huabang Biotechnology Overview
    • 12.14.3 Huabang Biotechnology Pig Disease Medication Sales, Price, Revenue and Gross Margin (2019-2024)
    • 12.14.4 Huabang Biotechnology Pig Disease Medication Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.14.5 Huabang Biotechnology Recent Developments
  • 12.15 Chengkang Pharmaceutical
    • 12.15.1 Chengkang Pharmaceutical Company Information
    • 12.15.2 Chengkang Pharmaceutical Overview
    • 12.15.3 Chengkang Pharmaceutical Pig Disease Medication Sales, Price, Revenue and Gross Margin (2019-2024)
    • 12.15.4 Chengkang Pharmaceutical Pig Disease Medication Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.15.5 Chengkang Pharmaceutical Recent Developments
  • 12.16 FANGTONG ANIMAL PHARMACEUTICAL
    • 12.16.1 FANGTONG ANIMAL PHARMACEUTICAL Company Information
    • 12.16.2 FANGTONG ANIMAL PHARMACEUTICAL Overview
    • 12.16.3 FANGTONG ANIMAL PHARMACEUTICAL Pig Disease Medication Sales, Price, Revenue and Gross Margin (2019-2024)
    • 12.16.4 FANGTONG ANIMAL PHARMACEUTICAL Pig Disease Medication Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.16.5 FANGTONG ANIMAL PHARMACEUTICAL Recent Developments
  • 12.17 Jin He Biotechnology
    • 12.17.1 Jin He Biotechnology Company Information
    • 12.17.2 Jin He Biotechnology Overview
    • 12.17.3 Jin He Biotechnology Pig Disease Medication Sales, Price, Revenue and Gross Margin (2019-2024)
    • 12.17.4 Jin He Biotechnology Pig Disease Medication Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.17.5 Jin He Biotechnology Recent Developments

13 Industry Chain and Sales Channels Analysis

  • 13.1 Pig Disease Medication Industry Chain Analysis
  • 13.2 Pig Disease Medication Key Raw Materials
    • 13.2.1 Key Raw Materials
    • 13.2.2 Raw Materials Key Suppliers
  • 13.3 Pig Disease Medication Production Mode & Process
  • 13.4 Pig Disease Medication Sales and Marketing
    • 13.4.1 Pig Disease Medication Sales Channels
    • 13.4.2 Pig Disease Medication Distributors
  • 13.5 Pig Disease Medication Customers

14 Pig Disease Medication Market Dynamics

  • 14.1 Pig Disease Medication Industry Trends
  • 14.2 Pig Disease Medication Market Drivers
  • 14.3 Pig Disease Medication Market Challenges
  • 14.4 Pig Disease Medication Market Restraints

15 Key Finding in The Global Pig Disease Medication Study

16 Appendix

  • 16.1 Research Methodology
    • 16.1.1 Methodology/Research Approach
    • 16.1.2 Data Source
  • 16.2 Author Details
  • 16.3 Disclaimer